Co-Diagnostics Revenue 2017-2025 | CODX

Co-Diagnostics revenue from 2017 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Co-Diagnostics Annual Revenue
(Millions of US $)
2024 $4
2023 $7
2022 $34
2021 $98
2020 $75
2019 $0
2018 $0
2017 $0
2016
Co-Diagnostics Quarterly Revenue
(Millions of US $)
2025-09-30 $0
2025-06-30 $0
2025-03-31 $0
2024-12-31 $0
2024-09-30 $1
2024-06-30 $3
2024-03-31 $0
2023-12-31 $4
2023-09-30 $2
2023-06-30 $0
2023-03-31 $1
2022-12-31 $1
2022-09-30 $5
2022-06-30 $5
2022-03-31 $23
2021-12-31 $20
2021-09-30 $30
2021-06-30 $27
2021-03-31 $20
2020-12-31 $27
2020-09-30 $22
2020-06-30 $24
2020-03-31 $2
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31
2016-12-31
2016-09-30
2016-06-30
Sector Industry Market Cap Revenue
Medical Medical Services $0.005B $0.004B
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $166.388B 30.55
HCA Healthcare (HCA) United States $109.378B 18.11
CVS Health (CVS) United States $102.418B 11.78
Elevance Health (ELV) United States $82.379B 12.08
Cencora (COR) United States $67.098B 21.63
Natera (NTRA) United States $32.905B 0.00
DiDi Global (DIDIY) China $23.862B 22.04
Labcorp Holdings (LH) United States $21.055B 16.05
Medpace Holdings (MEDP) United States $17.138B 42.55
EUROFINS SCIENT (ERFSF) Luxembourg $16.432B 0.00
BioMerieux (BMXMF) France $15.505B 0.00
Viatris (VTRS) United States $15.399B 5.74
ICON (ICLR) Ireland $14.802B 14.69
Solventum (SOLV) United States $13.881B 13.47
Revvity (RVTY) United States $12.487B 22.99
CochLear (CHEOY) Australia $11.568B 0.00
Charles River Laboratories (CRL) United States $10.778B 20.76
Avantor (AVTR) United States $8.591B 13.12
Sonic Healthcare (SKHHY) Australia $7.606B 0.00
Caris Life Sciences,�Inc (CAI) United States $7.449B 0.00
HealthEquity (HQY) United States $7.201B 26.93
BrightSpring Health Services (BTSG) United States $6.965B 41.53
PACS (PACS) United States $6.598B 40.12
Bausch + Lomb (BLCO) Canada $6.181B 40.58
Sotera Health (SHC) United States $5.392B 26.00
Alignment Healthcare (ALHC) United States $4.186B 0.00
Amplifon S.p.A (AMFPF) Italy $3.719B 21.70
GeneDx Holdings (WGS) United States $3.175B 55.76
Concentras Parent (CON) United States $2.599B 16.22
Organon (OGN) United States $2.192B 2.31
Progyny (PGNY) United States $2.176B 42.78
Surgery Partners (SGRY) United States $2.080B 26.80
Pediatrix Medical (MD) United States $1.904B 11.37
Establishment Labs Holdings (ESTA) United States $1.893B 0.00
Ardent Health (ARDT) United States $1.266B 4.13
Teladoc Health (TDOC) United States $1.241B 0.00
Nutex Health (NUTX) United States $1.221B 9.33
CareDx (CDNA) United States $1.038B 16.97
GoodRx Holdings (GDRX) United States $0.971B 15.89
Omada Health (OMDA) United States $0.934B 0.00
InnovAge Holding (INNV) United States $0.773B 0.00
Embecta (EMBC) United States $0.750B 4.26
COMPASS Pathways (CMPS) United Kingdom $0.708B 0.00
Sonida Senior Living (SNDA) United States $0.601B 0.00
Enhabit (EHAB) United States $0.554B 24.89
CryoPort (CYRX) United States $0.538B 0.00
Charming Medical (MCTA) Hong Kong, SAR China $0.497B 0.00
Strata Critical Medical (SRTA) United States $0.466B 0.00
SBC Medicals (SBC) United States $0.457B 8.42
Agilon Health (AGL) United States $0.394B 0.00
Auna S.A (AUNA) Luxembourg $0.349B 5.62
Oncology Institute (TOI) United States $0.347B 0.00
QDM (QDMI) Hong Kong, SAR China $0.320B 67.24
Shoulder Innovations (SI) United States $0.280B 0.00
So-Young (SY) China $0.270B 0.00
KindlyMD (NAKA) United States $0.204B 0.00
Beauty Health (SKIN) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Sera Prognostics (SERA) United States $0.139B 0.00
Ascend Wellness Holdings (AAWH) United States $0.137B 0.00
DocGo (DCGO) United States $0.085B 0.00
Biodesix (BDSX) United States $0.079B 0.00
Park Dental Partners (PARK) United States $0.063B 0.00
IceCure Medical (ICCM) Israel $0.045B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.045B 0.00
Pomdoctor - (POM) China $0.032B 0.00
Synergy CHC (SNYR) United States $0.020B 6.28
Intelligent Bio Solutions (INBS) United States $0.020B 0.00
OSR Holdings (OSRH) United States $0.019B 0.00
Basel Medical Group (BMGL) Singapore $0.014B 0.00
Lifeward (LFWD) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Pheton Holdings (PTHL) China $0.003B 0.00
XWELL (XWEL) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.000B 0.00
Cano Health (CANOQ) United States $0.000B 0.00